National Cancer Institute (NCI)

Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer (2020) Kho PF, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann M, et al. Journal article Prognostic gene expression signature for high-grade serous ovarian cancer (2020) Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, et al. Journal article Prediction and clinical utility of a contralateral breast cancer risk model (2019) Giardiello D, Steyerberg EW, Hauptmann M, Adank MA, Akdeniz D, Blomqvist C, Bojesen SE, et al. Journal article miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate (2019) Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hui J, Lacey NE, et al. Journal article Erratum to: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (Nature Communications, (2018), 9, 1, (3707), 10.1038/s41467-018-04989-w) (2019) Went M, Sud A, Foersti A, Halvarsson BM, Weinhold N, Kimber S, Van Duin M, et al. Journal article, Erratum Keratinocyte-intrinsic MHCII expression controls microbiota-induced Th1 cell responses (2019) Tamoutounour S, Han SJ, Deckers J, Constantinides MG, Hurabielle C, Harrison OJ, Bouladoux N, et al. Journal article Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT) (2019) Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, et al. Journal article Laboratory mice born to wild mice have natural microbiota and model human immune responses (2019) Rosshart SP, Herz J, Vassallo BG, Hunter A, Wall MK, Badger JH, Mcculloch JA, et al. Journal article Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection (2019) Yao C, Sun HW, Lacey NE, Ji Y, Moseman EA, Shih HY, Heuston EF, et al. Journal article KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer (2019) Mamounas EP, Geyer CE, Huang CS, Mano MS, Loibl S, Untch M, Wolmark N, et al. Conference contribution